Brilinta Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert

Full Prescribing Info

Description

Film-coated tablets 90 mg: Each tablet contains 90 mg of ticagrelor.
Film-coated tablets 60 mg: Each tablet contains 60 mg of ticagrelor.
Excipients/Inactive Ingredients: 90 mg film-coated tablet: Core: Mannitol (E421), Dibasic calcium phosphate, Magnesium stearate, Sodium starch glycolate, Hydroxypropyl cellulose.
Coating: Talc, Titanium dioxide (E171), Ferric oxide yellow (E172), Polyethylene glycol 400, Hypromellose.
60 mg film-coated tablet: Core: Mannitol (E421), Dibasic calcium phosphate, Magnesium stearate, Sodium starch glycolate, Hydroxypropyl cellulose.
Coating: Titanium dioxide (E171), Ferric oxide black (E172), Ferric oxide red (E172), Polyethylene glycol 400, Hypromellose.

Manufacturer:

AstraZeneca

Distributor:

DKSH